Publications by authors named "Hongying Sui"

Claim this Profile
G
GX15-070 enhances niraparib efficacy in ovarian cancer by promoting a shift in Mcl1-mediated DNA repair pathway from HR to NHEJ.
Jia-Jia Sheng, Yan He, Po-Wu Liu, Sheng-An Zheng, Nayiyuan Wu, Hong-Ying Sui

J Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRC75A-AS1 Drives the Epithelial-Mesenchymal Transition in Cervical Cancer by Binding IGF2BP1 and Inhibiting SYVN1-Mediated NLRP3 Ubiquitination.
Hongying Sui, Caixia Shi, Zhipeng Yan, Jinyang Chen, Lin Man

Mol Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRRC75A-AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression.
Hong-Ying Sui, Xiu-Ying Cui, Cai-Xia Shi, Zhi-Peng Yan, Hu-Cheng Li

Cancer Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer.
Hongying Sui, Caixia Shi, Zhipeng Yan, Mei Wu

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy.
Hongying Sui, Caixia Shi, Zhipeng Yan, Hucheng Li

Drug Des Devel Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis